XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2022 $ 640,572 $ 83 $ 701,052 $ (684) $ (59,879)
Balance, shares at Dec. 31, 2022   83,287,639      
Issuance upon vesting of restricted stock units, shares   53,935      
Issuance of common stock under employee stock purchase plan 165   165    
Issuance of common stock under employee stock purchase plan, shares   57,803      
Stock-based compensation expense 12,535   12,535    
Other comprehensive income (loss) 377     377  
Net loss (35,467)       (35,467)
Balance at Mar. 31, 2023 618,182 $ 83 713,752 (307) (95,346)
Balance, shares at Mar. 31, 2023   83,399,377      
Balance at Dec. 31, 2022 640,572 $ 83 701,052 (684) (59,879)
Balance, shares at Dec. 31, 2022   83,287,639      
Net loss (96,792)        
Balance at Sep. 30, 2023 581,730 $ 83 738,580 (262) (156,671)
Balance, shares at Sep. 30, 2023   83,435,513      
Balance at Mar. 31, 2023 618,182 $ 83 713,752 (307) (95,346)
Balance, shares at Mar. 31, 2023   83,399,377      
Stock-based compensation expense 12,353   12,353    
Other comprehensive income (loss) (3)     (3)  
Net loss (28,183)       (28,183)
Balance at Jun. 30, 2023 602,349 $ 83 726,105 (310) (123,529)
Balance, shares at Jun. 30, 2023   83,399,377      
Issuance of common stock under employee stock purchase plan 92   92    
Issuance of common stock under employee stock purchase plan, shares   36,136      
Stock-based compensation expense 12,383   12,383    
Other comprehensive income (loss) 48     48  
Net loss (33,142)       (33,142)
Balance at Sep. 30, 2023 581,730 $ 83 738,580 (262) (156,671)
Balance, shares at Sep. 30, 2023   83,435,513      
Balance at Dec. 31, 2023 555,192 $ 83 750,737 207 (195,835)
Balance, shares at Dec. 31, 2023   83,435,513      
Issuance upon vesting of restricted stock units   $ 1 (1)    
Issuance upon vesting of restricted stock units, shares   729,032      
Issuance of common stock under employee stock purchase plan 150   150    
Issuance of common stock under employee stock purchase plan, shares   58,555      
Stock-based compensation expense 12,586   12,586    
Other comprehensive income (loss) (388)     (388)  
Net loss (63,169)       (63,169)
Balance at Mar. 31, 2024 504,371 $ 84 763,472 (181) (259,004)
Balance, shares at Mar. 31, 2024   84,223,100      
Balance at Dec. 31, 2023 555,192 $ 83 750,737 207 (195,835)
Balance, shares at Dec. 31, 2023   83,435,513      
Net loss (134,842)        
Balance at Sep. 30, 2024 458,521 $ 84 788,473 641 (330,677)
Balance, shares at Sep. 30, 2024   84,463,059      
Balance at Mar. 31, 2024 504,371 $ 84 763,472 (181) (259,004)
Balance, shares at Mar. 31, 2024   84,223,100      
Issuance upon vesting of restricted stock units, shares   198,900      
Stock-based compensation expense 12,720   12,720    
Other comprehensive income (loss) (99)     (99)  
Net loss (40,522)       (40,522)
Balance at Jun. 30, 2024 476,470 $ 84 776,192 (280) (299,526)
Balance, shares at Jun. 30, 2024   84,422,000      
Issuance of common stock under employee stock purchase plan 117   117    
Issuance of common stock under employee stock purchase plan, shares   41,059      
Stock-based compensation expense 12,164   12,164    
Other comprehensive income (loss) 921     921  
Net loss (31,151)       (31,151)
Balance at Sep. 30, 2024 $ 458,521 $ 84 $ 788,473 $ 641 $ (330,677)
Balance, shares at Sep. 30, 2024   84,463,059